24
Participants
Start Date
August 31, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
May 31, 2030
HLX79 10mg/kg/Placebo+HLX01
Subjects with MN will receive HLX79 10mg/kg or placebo, combine with HLX01 375 mg/m2
HLX79 20mg/kg/Placebo + HLX01
Subjects with MN will receive HLX79 20mg/kg or placebo combined with HLX01 375 mg/m2
HLX79 30mg/kg/placebo+HLX01
Subjects with MN will receive HLX79 30mg/kg or placebo combined with HLX01 375 mg/m2
NOT_YET_RECRUITING
Beijing Tsinghua Changgung Hospital, Beijing
NOT_YET_RECRUITING
Peking University People's Hospital, Beijing
NOT_YET_RECRUITING
Xiangya Hospital Of Gentral South University, Changsha
NOT_YET_RECRUITING
Guangdong Provincial People's Hospital, Guangzhou
NOT_YET_RECRUITING
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
NOT_YET_RECRUITING
The First Affiliated Hospital Zhejiang University School Of Medicine, Hangzhou
NOT_YET_RECRUITING
The Second Hospital of Anhui Medical University, Hefei
NOT_YET_RECRUITING
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
NOT_YET_RECRUITING
Jiangxi Provincial People's Hospital, Nanchang
NOT_YET_RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
NOT_YET_RECRUITING
Jiangsu Province Hospital, Nanjing
NOT_YET_RECRUITING
Zhongdong Hospital Southeast University, Nanjing
RECRUITING
Shanghai General Hospital, Shanghai
NOT_YET_RECRUITING
Renmin Hospital Of Wuhan University, Wuhan
NOT_YET_RECRUITING
The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an
NOT_YET_RECRUITING
The First Affiliated Hospital Of Xiamen University, Xiamen
NOT_YET_RECRUITING
Su Bei People's Hospital, Yangzhou
Shanghai Henlius Biotech
INDUSTRY